In hepatocellular carcinoma tissues, RCAN1.4 was reported to inhibit the activation of and subsequently prevented nuclear localization of NFAT1 and restrained the liver cancer cell migration, proliferation [23]. Here, NFATC2 is linked to hepatocellular carcinoma.